Fortrea Holdings Inc. (FTRE) Dividend History

Fortrea Holdings Inc. (FTRE) is a global contract research organization (CRO) that provides clinical development services to the biopharmaceutical and healthcare industries. The company offers a range of solutions including clinical trial management, data management, biostatistics, and regulatory consulting, supporting the development of new drugs and treatments. Fortrea is focused on delivering innovative and efficient clinical research services to accelerate pharmaceutical development worldwide.

8 Moore Drive, Durham, NC, 27709
Phone: 877-495-0816
Website: https://www.fortrea.com

Dividend History

Fortrea Holdings Inc. currently does not pay dividends

Company News

  • Fortrea (FTRE) Q2 Revenue Jumps 7%

    Fortrea Holdings reported Q2 2025 revenue of $710.3 million, beating analyst estimates by 12.5%. Despite positive revenue growth and improved adjusted earnings, the company faced challenges including a significant goodwill impairment and a book-to-bill ratio below target.

    The Motley Fool
  • Fortrea Reports Second Quarter 2025 Results

    Fortrea reported Q2 2025 revenues of $710.3 million, with a GAAP net loss of $374.9 million, primarily due to a non-cash goodwill impairment charge. The company raised its 2025 revenue guidance and welcomed new CEO Anshul Thakral.

    GlobeNewswire Inc.
  • FTRE Investors Have Opportunity to Lead Fortrea Holdings Inc. Securities Fraud Lawsuit with the Schall Law Firm

    The Schall Law Firm is pursuing a class action lawsuit against Fortrea Holdings for allegedly making false and misleading statements about revenue projections, cost savings, and business model viability between July 2023 and February 2025.

    Benzinga
    Featured Companies: LH
Page data last updated 09/06/2025 08:58:15 UTC